Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,434,676
  • Shares Outstanding, K 512,538
  • Annual Sales, $ 11,127 M
  • Annual Income, $ 1,624 M
  • 60-Month Beta 1.00
  • Price/Sales 3.52
  • Price/Cash Flow 16.61
  • Price/Book 5.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.68
  • Number of Estimates 6
  • High Estimate 0.68
  • Low Estimate 0.67
  • Prior Year 0.70
  • Growth Rate Est. (year over year) -2.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.17 +5.17%
on 02/19/19
77.14 -0.25%
on 03/18/19
+3.52 (+4.79%)
since 02/15/19
3-Month
61.40 +25.33%
on 12/24/18
77.14 -0.25%
on 03/18/19
+11.84 (+18.18%)
since 12/18/18
52-Week
61.05 +26.04%
on 10/31/18
78.38 -1.82%
on 09/20/18
+9.06 (+13.35%)
since 03/16/18

Most Recent Stories

More News
Look for Shares of Baxter Intl Inc to Potentially Pullback after Yesterday's 1.19% Rise

Baxter Intl Inc (NYSE:BAX) traded in a range yesterday that spanned from a low of $76.39 to a high of $76.58. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $75.60...

BAX : 76.95 (+0.01%)
Baxter to Host First Quarter 2019 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019,...

BAX : 76.95 (+0.01%)
Baxter (BAX) Gets FDA Approval for Eptifibatide to Treat ACS

Baxter's (BAX) Eptifibatide is a platelet aggregation inhibitor that prevents platelets-specialized blood cells clotting.

WMGI : 32.16 (-0.53%)
ABMD : 333.25 (+0.01%)
IDXX : 215.74 (-0.22%)
BAX : 76.95 (+0.01%)
Baxter Announces U.S. FDA Approval and Launch of Ready-to-Use Cardiovascular Medicine Eptifibatide

--Eptifibatide is the latest addition to Baxter's broad line of ready-to-use medications intended to help enhance patient safety and support pharmacy efficiency

BAX : 76.95 (+0.01%)
Analysis: Positioning to Benefit within XPO Logistics, L3 Technologies, Domino's Pizza, Baxter International, Conduent, and Xylem -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of XPO Logistics, Inc. (NYSE:XPO),...

CNDT : 14.21 (+0.71%)
XPO : 51.52 (+3.77%)
BAX : 76.95 (+0.01%)
XYL : 78.33 (+2.07%)
LLL : 210.35 (+1.58%)
DPZ : 243.41 (-0.35%)
Baxter Honored as a 2019 "Top Company for Executive Women" by the National Association for Female Executives

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National...

BAX : 76.95 (+0.01%)
Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common...

BAX : 76.95 (+0.01%)
Post-Operative Pain Management Market Analysis by Size, Share, Growth, Mega Trends, Region Wise Analysis and Forecast to 2023

VRX.TO : 30.80 (-3.33%)
ENDP : 8.59 (+1.78%)
BAX : 76.95 (+0.01%)
TEVA : 16.64 (+0.79%)
HRTX : 24.40 (+2.95%)
Baxter's Acute Therapies Profile Strong, Competition Rife

Expanding product portfolio and strong presence in the international markets are key positives for Baxter (BAX) at the moment.

ABT : 78.83 (-1.29%)
SRDX : 47.56 (-8.73%)
BAX : 76.95 (+0.01%)
CSII : 39.46 (-0.58%)
Baxter to Present at the Barclays Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019. Jay Saccaro, Baxter's...

BAX : 76.95 (+0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade BAX with:

Business Summary

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare...

See More

Key Turning Points

2nd Resistance Point 77.50
1st Resistance Point 77.23
Last Price 76.95
1st Support Level 76.59
2nd Support Level 76.22

See More

52-Week High 78.38
Last Price 76.95
Fibonacci 61.8% 71.76
Fibonacci 50% 69.71
Fibonacci 38.2% 67.67
52-Week Low 61.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar